Senior Oncology Medical Science Liaison – CCA/HCC

EVERSANA; Philadelphia (Philadelphia County); On-site; USD 110,000 - 170,000; Full time

Job summary

EVERSANA is seeking an experienced Medical Science Liaison (MSL/Sr. MSL) to serve as a field-based scientific expert in cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC). You will engage healthcare professionals, share data, and build scientific relationships under regulatory guidelines.

The role requires advanced degrees, MSL experience (and rare disease/oncology exposure), and travel up to 70%. Collaboration with R&D and payer communities is essential to advance clinical programs.

Qualifications

• An advanced degree (e.g., PharmD, PhD, MD, MSN, or NP/PA) is required.
• MSL: A minimum of 2 years previous MSL experience with at least 1 year in rare disease, oncology and/or immunology with knowledge of targeted therapies.
• Sr. MSL: 5 years pharma experience and 3 years rare disease/oncology/immunology experience.
• Prior product launch experience is required.
• Excellent written and oral presentation skills; ability to travel ~70%.

Responsibilities

• Serve as the primary point of contact within the assigned geographic area.
• Maintain oncology and immunotherapy clinical expertise with focus on CCA and HCC.
• Engage in compliant scientific peer exchange with KOLs and HCPs.
• Develop and track KOL engagement plans in the region.
• Collaborate with R&D to support sites and investigators in company-sponsored trials.
• Represent EVERSANA at medical meetings and prepare internal congress reports.

Skills

MSL experience

Rare disease experience

Oncology/immunology knowledge

Product launch

Communication skills

Data presentation to KOLs

HCC/CCA standards of care

Payer communications

Education

Advanced degree

Job description

EVERSANA is seeking an experienced Medical Science Liaison (MSL/Sr. MSL) to serve as a field-based scientific expert in cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC). You will engage healthcare professionals, share data, and build scientific relationships under regulatory guidelines.

The role requires advanced degrees, MSL experience (and rare disease/oncology exposure), and travel up to 70%. Collaboration with R&D and payer communities is essential to advance clinical programs.